David Faraoni, M.D., Ph.D.
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name | Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Antifibrinolytic Agents | 27 | 2024 | 289 | 8.560 |
Why?
|
| Cardiac Surgical Procedures | 54 | 2024 | 3683 | 7.360 |
Why?
|
| Tranexamic Acid | 23 | 2024 | 174 | 7.010 |
Why?
|
| Thrombelastography | 14 | 2021 | 194 | 4.230 |
Why?
|
| Cardiopulmonary Bypass | 24 | 2023 | 1097 | 4.010 |
Why?
|
| Blood Loss, Surgical | 22 | 2023 | 642 | 3.750 |
Why?
|
| Heart Defects, Congenital | 32 | 2024 | 4712 | 3.680 |
Why?
|
| Postoperative Hemorrhage | 19 | 2022 | 419 | 3.650 |
Why?
|
| Blood Transfusion | 25 | 2024 | 1309 | 3.210 |
Why?
|
| Perioperative Care | 15 | 2019 | 1043 | 2.850 |
Why?
|
| Erythrocyte Transfusion | 12 | 2022 | 575 | 2.720 |
Why?
|
| Surgical Procedures, Operative | 16 | 2022 | 1932 | 2.180 |
Why?
|
| Fibrinolysis | 8 | 2021 | 331 | 2.170 |
Why?
|
| Blood Coagulation Disorders | 10 | 2023 | 350 | 1.870 |
Why?
|
| Postoperative Complications | 27 | 2023 | 15832 | 1.670 |
Why?
|
| Heparin | 6 | 2024 | 1636 | 1.630 |
Why?
|
| Hemorrhage | 17 | 2024 | 3467 | 1.600 |
Why?
|
| Blood Coagulation | 10 | 2021 | 1162 | 1.520 |
Why?
|
| Hemostasis | 8 | 2022 | 468 | 1.510 |
Why?
|
| Extracorporeal Membrane Oxygenation | 9 | 2023 | 1483 | 1.420 |
Why?
|
| Anemia | 9 | 2022 | 1514 | 1.420 |
Why?
|
| Thrombosis | 9 | 2023 | 2957 | 1.390 |
Why?
|
| Hemostatics | 7 | 2023 | 246 | 1.270 |
Why?
|
| Hirudins | 5 | 2024 | 179 | 1.260 |
Why?
|
| Anticoagulants | 18 | 2024 | 4852 | 1.190 |
Why?
|
| Thoracic Surgery | 4 | 2023 | 727 | 1.190 |
Why?
|
| Blood Coagulation Factors | 6 | 2023 | 371 | 1.130 |
Why?
|
| Spinal Fusion | 4 | 2021 | 1307 | 1.130 |
Why?
|
| Infant | 55 | 2024 | 36535 | 1.070 |
Why?
|
| Child | 78 | 2024 | 80917 | 1.050 |
Why?
|
| Factor VIIa | 5 | 2023 | 103 | 1.040 |
Why?
|
| Infant, Newborn | 36 | 2024 | 26422 | 0.890 |
Why?
|
| Child, Preschool | 46 | 2024 | 42669 | 0.880 |
Why?
|
| Hospital Mortality | 13 | 2022 | 5349 | 0.860 |
Why?
|
| Fibrinogen | 3 | 2017 | 891 | 0.850 |
Why?
|
| Intermittent Pneumatic Compression Devices | 3 | 2018 | 28 | 0.790 |
Why?
|
| Preoperative Care | 8 | 2018 | 2258 | 0.750 |
Why?
|
| Hospital Costs | 3 | 2017 | 957 | 0.740 |
Why?
|
| Intraoperative Care | 4 | 2021 | 770 | 0.730 |
Why?
|
| Postpartum Hemorrhage | 5 | 2022 | 275 | 0.730 |
Why?
|
| Antithrombins | 3 | 2018 | 294 | 0.720 |
Why?
|
| Humans | 170 | 2024 | 768166 | 0.710 |
Why?
|
| Databases, Factual | 14 | 2024 | 8080 | 0.690 |
Why?
|
| Perioperative Period | 5 | 2022 | 253 | 0.660 |
Why?
|
| Aprotinin | 5 | 2022 | 94 | 0.650 |
Why?
|
| Cyanosis | 3 | 2019 | 82 | 0.640 |
Why?
|
| Risk Assessment | 20 | 2023 | 24315 | 0.640 |
Why?
|
| Blood Platelets | 2 | 2021 | 2479 | 0.610 |
Why?
|
| Tissue Plasminogen Activator | 4 | 2021 | 1165 | 0.610 |
Why?
|
| Antithrombin III | 1 | 2018 | 128 | 0.600 |
Why?
|
| Practice Guidelines as Topic | 6 | 2019 | 7454 | 0.600 |
Why?
|
| Plasma | 4 | 2022 | 585 | 0.580 |
Why?
|
| Recombinant Proteins | 9 | 2024 | 6514 | 0.570 |
Why?
|
| Retrospective Studies | 51 | 2023 | 81762 | 0.570 |
Why?
|
| Scoliosis | 2 | 2021 | 793 | 0.540 |
Why?
|
| Venous Thromboembolism | 4 | 2018 | 1883 | 0.530 |
Why?
|
| Iron | 2 | 2021 | 1813 | 0.520 |
Why?
|
| Erythrocytes | 3 | 2022 | 2418 | 0.510 |
Why?
|
| Dexmedetomidine | 1 | 2020 | 320 | 0.510 |
Why?
|
| Pediatrics | 4 | 2020 | 3629 | 0.500 |
Why?
|
| Anesthesia | 6 | 2023 | 1596 | 0.500 |
Why?
|
| Cardiopulmonary Resuscitation | 1 | 2023 | 997 | 0.500 |
Why?
|
| Hemostasis, Surgical | 2 | 2018 | 128 | 0.490 |
Why?
|
| Hemorrhagic Disorders | 1 | 2015 | 34 | 0.490 |
Why?
|
| Plasma Substitutes | 1 | 2015 | 57 | 0.490 |
Why?
|
| Craniosynostoses | 1 | 2019 | 415 | 0.490 |
Why?
|
| Oral Medicine | 1 | 2015 | 36 | 0.480 |
Why?
|
| Skull | 1 | 2019 | 820 | 0.480 |
Why?
|
| Hemodilution | 2 | 2018 | 120 | 0.480 |
Why?
|
| Fluid Therapy | 3 | 2015 | 587 | 0.470 |
Why?
|
| Heart Arrest | 2 | 2023 | 1516 | 0.450 |
Why?
|
| Medication Therapy Management | 1 | 2015 | 131 | 0.450 |
Why?
|
| Achondroplasia | 1 | 2013 | 28 | 0.450 |
Why?
|
| Comorbidity | 6 | 2020 | 10590 | 0.440 |
Why?
|
| Point-of-Care Systems | 4 | 2016 | 1238 | 0.430 |
Why?
|
| Wounds and Injuries | 5 | 2018 | 2517 | 0.430 |
Why?
|
| Serine Proteinase Inhibitors | 1 | 2014 | 174 | 0.420 |
Why?
|
| Length of Stay | 7 | 2023 | 6498 | 0.420 |
Why?
|
| Vitamin K | 1 | 2015 | 314 | 0.410 |
Why?
|
| Anesthesiology | 7 | 2023 | 1137 | 0.410 |
Why?
|
| Delivery of Health Care, Integrated | 1 | 2020 | 951 | 0.400 |
Why?
|
| Cardiac Output | 2 | 2023 | 838 | 0.390 |
Why?
|
| Critical Care | 9 | 2023 | 2715 | 0.370 |
Why?
|
| Treatment Outcome | 27 | 2024 | 65371 | 0.360 |
Why?
|
| Neurosurgical Procedures | 3 | 2019 | 2076 | 0.360 |
Why?
|
| Ketamine | 2 | 2023 | 527 | 0.350 |
Why?
|
| Airway Management | 1 | 2013 | 326 | 0.350 |
Why?
|
| Pleural Neoplasms | 1 | 2015 | 612 | 0.340 |
Why?
|
| Catheterization, Peripheral | 1 | 2013 | 347 | 0.340 |
Why?
|
| Male | 61 | 2022 | 364719 | 0.340 |
Why?
|
| Heart Transplantation | 2 | 2021 | 3301 | 0.340 |
Why?
|
| Risk Factors | 30 | 2023 | 74944 | 0.340 |
Why?
|
| Incidence | 15 | 2021 | 21538 | 0.340 |
Why?
|
| Monitoring, Physiologic | 3 | 2016 | 1798 | 0.330 |
Why?
|
| Female | 63 | 2023 | 397192 | 0.330 |
Why?
|
| Penis | 1 | 2010 | 209 | 0.330 |
Why?
|
| Peptide Fragments | 5 | 2024 | 5151 | 0.330 |
Why?
|
| Jugular Veins | 1 | 2010 | 211 | 0.320 |
Why?
|
| Cardiology | 1 | 2020 | 1702 | 0.320 |
Why?
|
| Anesthetics, Combined | 1 | 2009 | 43 | 0.320 |
Why?
|
| Orthopedic Procedures | 2 | 2021 | 1279 | 0.320 |
Why?
|
| Renal Insufficiency | 1 | 2015 | 812 | 0.320 |
Why?
|
| Heart-Assist Devices | 2 | 2021 | 1292 | 0.320 |
Why?
|
| Heart Diseases | 2 | 2020 | 2819 | 0.310 |
Why?
|
| Mesothelioma | 1 | 2015 | 811 | 0.310 |
Why?
|
| Randomized Controlled Trials as Topic | 5 | 2020 | 10399 | 0.310 |
Why?
|
| Catheterization, Central Venous | 1 | 2013 | 537 | 0.310 |
Why?
|
| Disseminated Intravascular Coagulation | 2 | 2019 | 187 | 0.300 |
Why?
|
| Catheters, Indwelling | 1 | 2010 | 436 | 0.290 |
Why?
|
| ROC Curve | 6 | 2019 | 3628 | 0.290 |
Why?
|
| Protamines | 3 | 2018 | 112 | 0.290 |
Why?
|
| Analgesics | 2 | 2019 | 1071 | 0.290 |
Why?
|
| Systemic Inflammatory Response Syndrome | 1 | 2012 | 621 | 0.280 |
Why?
|
| Adolescent | 28 | 2023 | 89169 | 0.280 |
Why?
|
| Anesthesia, General | 3 | 2021 | 1189 | 0.280 |
Why?
|
| Thrombocytopenia | 1 | 2015 | 1179 | 0.270 |
Why?
|
| Quality Improvement | 2 | 2019 | 3857 | 0.270 |
Why?
|
| Europe | 5 | 2018 | 3436 | 0.270 |
Why?
|
| Hematopoietic Stem Cell Transplantation | 2 | 2021 | 5717 | 0.270 |
Why?
|
| Hemoglobins | 3 | 2021 | 1531 | 0.260 |
Why?
|
| Oxygen | 1 | 2018 | 4270 | 0.260 |
Why?
|
| Coronavirus Infections | 2 | 2020 | 3115 | 0.250 |
Why?
|
| Anesthetics, Intravenous | 1 | 2009 | 397 | 0.250 |
Why?
|
| Algorithms | 5 | 2020 | 14164 | 0.250 |
Why?
|
| Pneumonia, Viral | 2 | 2020 | 3238 | 0.250 |
Why?
|
| Postoperative Care | 4 | 2022 | 1480 | 0.250 |
Why?
|
| Coronary Artery Bypass | 1 | 2014 | 2191 | 0.240 |
Why?
|
| Area Under Curve | 2 | 2020 | 1643 | 0.240 |
Why?
|
| Calibration | 2 | 2017 | 819 | 0.240 |
Why?
|
| Electroencephalography | 2 | 2010 | 6314 | 0.220 |
Why?
|
| Subarachnoid Hemorrhage | 1 | 2011 | 1024 | 0.220 |
Why?
|
| Factor IX | 1 | 2023 | 76 | 0.220 |
Why?
|
| Nerve Block | 1 | 2010 | 716 | 0.220 |
Why?
|
| Patient Readmission | 1 | 2017 | 3288 | 0.220 |
Why?
|
| Dose-Response Relationship, Drug | 5 | 2021 | 10760 | 0.210 |
Why?
|
| Blood Coagulation Tests | 4 | 2017 | 270 | 0.210 |
Why?
|
| Milrinone | 1 | 2023 | 86 | 0.210 |
Why?
|
| Health Services Accessibility | 1 | 2020 | 5520 | 0.200 |
Why?
|
| Monitoring, Intraoperative | 3 | 2015 | 948 | 0.200 |
Why?
|
| Predictive Value of Tests | 8 | 2020 | 15454 | 0.200 |
Why?
|
| Ontario | 2 | 2020 | 403 | 0.200 |
Why?
|
| Extremities | 2 | 2019 | 870 | 0.200 |
Why?
|
| Cardiac Output, Low | 1 | 2023 | 192 | 0.200 |
Why?
|
| Double-Blind Method | 5 | 2022 | 12465 | 0.200 |
Why?
|
| Health Care Costs | 1 | 2015 | 3239 | 0.200 |
Why?
|
| Severity of Illness Index | 3 | 2019 | 15948 | 0.200 |
Why?
|
| Research Design | 2 | 2023 | 6211 | 0.200 |
Why?
|
| Blood Banks | 2 | 2020 | 108 | 0.190 |
Why?
|
| Artifacts | 1 | 2010 | 1926 | 0.190 |
Why?
|
| Norwood Procedures | 1 | 2023 | 192 | 0.190 |
Why?
|
| Propensity Score | 4 | 2017 | 1969 | 0.190 |
Why?
|
| Hospitals, Pediatric | 6 | 2021 | 1876 | 0.180 |
Why?
|
| Prospective Studies | 11 | 2021 | 54926 | 0.180 |
Why?
|
| Age Factors | 9 | 2021 | 18412 | 0.180 |
Why?
|
| Consensus | 5 | 2023 | 3212 | 0.180 |
Why?
|
| Decontamination | 1 | 2020 | 73 | 0.170 |
Why?
|
| Acute Kidney Injury | 1 | 2012 | 1942 | 0.170 |
Why?
|
| Ductus Arteriosus, Patent | 1 | 2021 | 216 | 0.170 |
Why?
|
| Echocardiography | 1 | 2013 | 5047 | 0.170 |
Why?
|
| Pain, Postoperative | 3 | 2021 | 1765 | 0.170 |
Why?
|
| Liver Transplantation | 3 | 2023 | 2401 | 0.170 |
Why?
|
| Switzerland | 1 | 2020 | 323 | 0.170 |
Why?
|
| Heart | 3 | 2021 | 4446 | 0.160 |
Why?
|
| Societies, Medical | 5 | 2018 | 3968 | 0.160 |
Why?
|
| Adsorption | 1 | 2019 | 198 | 0.160 |
Why?
|
| Hematocrit | 2 | 2017 | 623 | 0.150 |
Why?
|
| Postoperative Period | 3 | 2018 | 1826 | 0.150 |
Why?
|
| Dietary Supplements | 2 | 2021 | 3445 | 0.150 |
Why?
|
| Craniofacial Abnormalities | 1 | 2020 | 320 | 0.150 |
Why?
|
| Pilot Projects | 3 | 2016 | 8741 | 0.150 |
Why?
|
| Factor XIII | 1 | 2017 | 59 | 0.150 |
Why?
|
| Early Ambulation | 1 | 2018 | 49 | 0.150 |
Why?
|
| Respiration Disorders | 1 | 2021 | 364 | 0.150 |
Why?
|
| Logistic Models | 6 | 2019 | 13290 | 0.140 |
Why?
|
| Pipecolic Acids | 1 | 2018 | 77 | 0.140 |
Why?
|
| Infectious Disease Transmission, Patient-to-Professional | 1 | 2020 | 249 | 0.140 |
Why?
|
| Odds Ratio | 4 | 2019 | 9669 | 0.140 |
Why?
|
| Hematinics | 2 | 2018 | 282 | 0.140 |
Why?
|
| Hospitals, Special | 1 | 2017 | 90 | 0.140 |
Why?
|
| Analgesics, Opioid | 3 | 2023 | 3837 | 0.140 |
Why?
|
| Survival Rate | 5 | 2021 | 12840 | 0.140 |
Why?
|
| Cohort Studies | 8 | 2021 | 41754 | 0.140 |
Why?
|
| Bibliometrics | 1 | 2021 | 354 | 0.140 |
Why?
|
| Evidence-Based Medicine | 3 | 2020 | 3706 | 0.140 |
Why?
|
| Evoked Potentials, Motor | 1 | 2020 | 465 | 0.140 |
Why?
|
| Erythrocyte Count | 1 | 2017 | 157 | 0.140 |
Why?
|
| Shock | 1 | 2019 | 316 | 0.140 |
Why?
|
| Cardiovascular Surgical Procedures | 1 | 2018 | 193 | 0.140 |
Why?
|
| Hospitalization | 2 | 2018 | 10840 | 0.130 |
Why?
|
| Hypertension, Pulmonary | 2 | 2018 | 1605 | 0.130 |
Why?
|
| Preoperative Period | 2 | 2020 | 565 | 0.130 |
Why?
|
| Anemia, Iron-Deficiency | 1 | 2020 | 372 | 0.130 |
Why?
|
| Jehovah's Witnesses | 1 | 2016 | 13 | 0.130 |
Why?
|
| Pulmonary Atresia | 1 | 2017 | 159 | 0.130 |
Why?
|
| Heparin Antagonists | 1 | 2016 | 34 | 0.130 |
Why?
|
| Multivariate Analysis | 4 | 2016 | 12077 | 0.130 |
Why?
|
| Intubation, Intratracheal | 2 | 2023 | 1359 | 0.130 |
Why?
|
| Heparin, Low-Molecular-Weight | 1 | 2018 | 345 | 0.130 |
Why?
|
| Vasoconstrictor Agents | 1 | 2019 | 656 | 0.130 |
Why?
|
| Embolism, Air | 1 | 2016 | 110 | 0.130 |
Why?
|
| Equipment Design | 2 | 2021 | 3522 | 0.120 |
Why?
|
| Postoperative Nausea and Vomiting | 1 | 2016 | 128 | 0.120 |
Why?
|
| Vasodilation | 1 | 2019 | 967 | 0.120 |
Why?
|
| Hypnotics and Sedatives | 2 | 2023 | 1191 | 0.120 |
Why?
|
| Spinal Cord Diseases | 1 | 2018 | 291 | 0.120 |
Why?
|
| Clinical Laboratory Techniques | 1 | 2020 | 747 | 0.120 |
Why?
|
| Sex Factors | 2 | 2019 | 10632 | 0.120 |
Why?
|
| Thrombophilia | 1 | 2017 | 308 | 0.120 |
Why?
|
| Isotonic Solutions | 1 | 2015 | 119 | 0.120 |
Why?
|
| Time Factors | 7 | 2021 | 40218 | 0.120 |
Why?
|
| Spine | 1 | 2021 | 1140 | 0.120 |
Why?
|
| Respiration | 1 | 2021 | 1665 | 0.120 |
Why?
|
| Infusions, Intravenous | 1 | 2019 | 2230 | 0.120 |
Why?
|
| Needs Assessment | 1 | 2020 | 1141 | 0.110 |
Why?
|
| Pandemics | 4 | 2023 | 8748 | 0.110 |
Why?
|
| Follow-Up Studies | 6 | 2019 | 39348 | 0.110 |
Why?
|
| von Willebrand Factor | 1 | 2017 | 680 | 0.110 |
Why?
|
| Drug Monitoring | 2 | 2023 | 964 | 0.110 |
Why?
|
| Resuscitation | 2 | 2015 | 679 | 0.110 |
Why?
|
| Infectious Disease Transmission, Vertical | 1 | 2020 | 1354 | 0.110 |
Why?
|
| Heart Septal Defects, Atrial | 1 | 2016 | 452 | 0.110 |
Why?
|
| Infection Control | 1 | 2020 | 985 | 0.100 |
Why?
|
| Hematoma | 1 | 2018 | 766 | 0.100 |
Why?
|
| Child Behavior | 1 | 2019 | 864 | 0.100 |
Why?
|
| Sleep Apnea Syndromes | 1 | 2021 | 984 | 0.100 |
Why?
|
| Shock, Septic | 1 | 2019 | 774 | 0.100 |
Why?
|
| Hernia, Diaphragmatic, Traumatic | 1 | 2012 | 6 | 0.100 |
Why?
|
| Intraoperative Period | 1 | 2013 | 513 | 0.100 |
Why?
|
| Pyridones | 2 | 2015 | 819 | 0.100 |
Why?
|
| Health Services Needs and Demand | 1 | 2020 | 1406 | 0.100 |
Why?
|
| Fibrin Fibrinogen Degradation Products | 1 | 2014 | 425 | 0.100 |
Why?
|
| Case-Control Studies | 3 | 2020 | 22291 | 0.100 |
Why?
|
| Albumins | 1 | 2015 | 577 | 0.100 |
Why?
|
| United States | 11 | 2023 | 73039 | 0.100 |
Why?
|
| Intracranial Hemorrhages | 1 | 2018 | 810 | 0.100 |
Why?
|
| Hernia, Abdominal | 1 | 2012 | 58 | 0.100 |
Why?
|
| Host-Pathogen Interactions | 1 | 2020 | 1469 | 0.100 |
Why?
|
| Aortic Aneurysm | 1 | 2016 | 649 | 0.090 |
Why?
|
| Forecasting | 2 | 2017 | 2945 | 0.090 |
Why?
|
| Patient Positioning | 1 | 2013 | 332 | 0.090 |
Why?
|
| Preanesthetic Medication | 1 | 2010 | 48 | 0.090 |
Why?
|
| Recovery Room | 1 | 2010 | 34 | 0.090 |
Why?
|
| Combined Modality Therapy | 2 | 2013 | 8542 | 0.090 |
Why?
|
| Consciousness Monitors | 1 | 2010 | 21 | 0.090 |
Why?
|
| Piperidines | 2 | 2009 | 1667 | 0.090 |
Why?
|
| Ischemia | 1 | 2019 | 1900 | 0.090 |
Why?
|
| Chi-Square Distribution | 1 | 2016 | 3436 | 0.090 |
Why?
|
| Lung Neoplasms | 1 | 2015 | 13586 | 0.090 |
Why?
|
| Prognosis | 3 | 2016 | 30010 | 0.090 |
Why?
|
| Warfarin | 2 | 2016 | 1493 | 0.090 |
Why?
|
| Entropy | 1 | 2010 | 211 | 0.080 |
Why?
|
| Carotid Artery Injuries | 1 | 2010 | 96 | 0.080 |
Why?
|
| Periodicals as Topic | 1 | 2021 | 1465 | 0.080 |
Why?
|
| Adult | 16 | 2022 | 223646 | 0.080 |
Why?
|
| Reference Values | 1 | 2017 | 4938 | 0.080 |
Why?
|
| Decision Support Techniques | 1 | 2019 | 2008 | 0.080 |
Why?
|
| Administration, Oral | 2 | 2014 | 4030 | 0.080 |
Why?
|
| Circumcision, Male | 1 | 2010 | 148 | 0.080 |
Why?
|
| Heart Valve Diseases | 1 | 2017 | 1030 | 0.080 |
Why?
|
| Brain Neoplasms | 1 | 2010 | 9118 | 0.080 |
Why?
|
| Occipital Lobe | 1 | 2010 | 376 | 0.080 |
Why?
|
| Anesthetics, Dissociative | 1 | 2009 | 81 | 0.080 |
Why?
|
| Patient Discharge | 1 | 2021 | 3479 | 0.080 |
Why?
|
| Models, Statistical | 2 | 2020 | 5107 | 0.080 |
Why?
|
| Laparotomy | 1 | 2010 | 458 | 0.070 |
Why?
|
| Goals | 1 | 2013 | 717 | 0.070 |
Why?
|
| Aorta | 1 | 2016 | 2045 | 0.070 |
Why?
|
| Cough | 1 | 2012 | 598 | 0.070 |
Why?
|
| Thoracotomy | 1 | 2009 | 374 | 0.070 |
Why?
|
| Survival Analysis | 1 | 2020 | 10101 | 0.070 |
Why?
|
| Mortality | 1 | 2019 | 2911 | 0.070 |
Why?
|
| Kinetics | 1 | 2015 | 6329 | 0.070 |
Why?
|
| Anesthesia, Intravenous | 2 | 2021 | 130 | 0.070 |
Why?
|
| Intensive Care Units | 3 | 2023 | 3800 | 0.070 |
Why?
|
| Hospitals | 2 | 2022 | 3886 | 0.070 |
Why?
|
| Pyrazoles | 2 | 2015 | 2028 | 0.070 |
Why?
|
| Cost-Benefit Analysis | 1 | 2020 | 5536 | 0.070 |
Why?
|
| Middle Aged | 11 | 2019 | 223492 | 0.070 |
Why?
|
| Ultrasonography | 2 | 2010 | 6004 | 0.070 |
Why?
|
| Health Care Surveys | 1 | 2014 | 2434 | 0.070 |
Why?
|
| Child Development | 1 | 2019 | 2330 | 0.070 |
Why?
|
| Reproducibility of Results | 4 | 2020 | 20227 | 0.070 |
Why?
|
| Aortic Valve | 1 | 2017 | 1970 | 0.070 |
Why?
|
| Single-Blind Method | 1 | 2010 | 1587 | 0.070 |
Why?
|
| Aged | 12 | 2021 | 171504 | 0.070 |
Why?
|
| Analgesia, Epidural | 1 | 2009 | 332 | 0.070 |
Why?
|
| Risk | 2 | 2017 | 9613 | 0.060 |
Why?
|
| France | 2 | 2018 | 497 | 0.060 |
Why?
|
| Canada | 2 | 2023 | 2130 | 0.060 |
Why?
|
| Meta-Analysis as Topic | 1 | 2010 | 1363 | 0.060 |
Why?
|
| Electronic Health Records | 1 | 2023 | 4887 | 0.060 |
Why?
|
| Sepsis | 1 | 2019 | 2608 | 0.060 |
Why?
|
| Peripheral Arterial Disease | 1 | 2016 | 1304 | 0.060 |
Why?
|
| Homeostasis | 1 | 2015 | 3348 | 0.060 |
Why?
|
| Pregnancy | 4 | 2022 | 30256 | 0.060 |
Why?
|
| Drug Interactions | 1 | 2009 | 1419 | 0.060 |
Why?
|
| Dyspnea | 1 | 2012 | 1352 | 0.060 |
Why?
|
| Treatment Failure | 1 | 2010 | 2661 | 0.060 |
Why?
|
| Frontal Lobe | 1 | 2010 | 1426 | 0.060 |
Why?
|
| Sensitivity and Specificity | 2 | 2019 | 14729 | 0.060 |
Why?
|
| Inpatients | 1 | 2015 | 2566 | 0.050 |
Why?
|
| Anesthetics, Local | 1 | 2010 | 1005 | 0.050 |
Why?
|
| Intraoperative Complications | 1 | 2010 | 1171 | 0.050 |
Why?
|
| Pain Measurement | 2 | 2010 | 3583 | 0.050 |
Why?
|
| Massachusetts | 1 | 2016 | 8890 | 0.050 |
Why?
|
| Propofol | 1 | 2009 | 608 | 0.050 |
Why?
|
| Emergency Medical Services | 1 | 2014 | 1947 | 0.050 |
Why?
|
| Heart Ventricles | 1 | 2015 | 3841 | 0.050 |
Why?
|
| Fibrinolysin | 1 | 2022 | 130 | 0.050 |
Why?
|
| Lung | 1 | 2021 | 10099 | 0.050 |
Why?
|
| Western Australia | 1 | 2022 | 41 | 0.050 |
Why?
|
| Internet | 1 | 2014 | 3110 | 0.050 |
Why?
|
| Tablets | 1 | 2022 | 149 | 0.050 |
Why?
|
| Blood Component Transfusion | 1 | 2022 | 141 | 0.050 |
Why?
|
| Ligation | 1 | 2021 | 446 | 0.050 |
Why?
|
| Equipment Reuse | 1 | 2020 | 45 | 0.040 |
Why?
|
| Attitude of Health Personnel | 1 | 2014 | 3929 | 0.040 |
Why?
|
| Cardiotonic Agents | 1 | 2023 | 542 | 0.040 |
Why?
|
| Filtration | 1 | 2020 | 229 | 0.040 |
Why?
|
| Carbon Dioxide | 1 | 2023 | 1148 | 0.040 |
Why?
|
| Prevalence | 1 | 2016 | 15869 | 0.040 |
Why?
|
| Hemodynamics | 2 | 2023 | 4194 | 0.040 |
Why?
|
| Platelet Aggregation Inhibitors | 2 | 2023 | 2763 | 0.040 |
Why?
|
| Awareness | 1 | 2023 | 654 | 0.040 |
Why?
|
| Coagulants | 1 | 2018 | 45 | 0.040 |
Why?
|
| Clinical Competence | 1 | 2014 | 4858 | 0.040 |
Why?
|
| Matched-Pair Analysis | 1 | 2019 | 285 | 0.040 |
Why?
|
| Stockings, Compression | 1 | 2018 | 36 | 0.040 |
Why?
|
| Acid-Base Equilibrium | 1 | 2019 | 180 | 0.040 |
Why?
|
| Blood Donors | 1 | 2020 | 343 | 0.040 |
Why?
|
| Blood Gas Analysis | 1 | 2019 | 384 | 0.040 |
Why?
|
| Young Adult | 3 | 2017 | 60066 | 0.040 |
Why?
|
| American Heart Association | 1 | 2022 | 1050 | 0.040 |
Why?
|
| Principal Component Analysis | 1 | 2021 | 948 | 0.040 |
Why?
|
| Peer Review, Research | 1 | 2021 | 344 | 0.040 |
Why?
|
| Blood Chemical Analysis | 1 | 2019 | 435 | 0.040 |
Why?
|
| Laparoscopy | 1 | 2009 | 2041 | 0.030 |
Why?
|
| Circulatory Arrest, Deep Hypothermia Induced | 1 | 2017 | 82 | 0.030 |
Why?
|
| Ventricular Septum | 1 | 2017 | 76 | 0.030 |
Why?
|
| Delphi Technique | 1 | 2020 | 891 | 0.030 |
Why?
|
| Heparin Lyase | 1 | 2016 | 37 | 0.030 |
Why?
|
| Whole Blood Coagulation Time | 1 | 2016 | 30 | 0.030 |
Why?
|
| Postpartum Period | 1 | 2023 | 1198 | 0.030 |
Why?
|
| Critical Illness | 2 | 2020 | 2756 | 0.030 |
Why?
|
| International Normalized Ratio | 1 | 2017 | 382 | 0.030 |
Why?
|
| Body Surface Area | 1 | 2016 | 205 | 0.030 |
Why?
|
| Platelet Transfusion | 1 | 2018 | 301 | 0.030 |
Why?
|
| Necrosis | 1 | 2019 | 1616 | 0.030 |
Why?
|
| Vena Cava Filters | 1 | 2018 | 270 | 0.030 |
Why?
|
| Erythrocyte Aging | 1 | 2014 | 52 | 0.030 |
Why?
|
| Siblings | 1 | 2019 | 828 | 0.030 |
Why?
|
| Platelet Count | 1 | 2017 | 787 | 0.030 |
Why?
|
| Specialties, Surgical | 1 | 2019 | 391 | 0.030 |
Why?
|
| Antiemetics | 1 | 2016 | 188 | 0.030 |
Why?
|
| Kidney Function Tests | 1 | 2016 | 684 | 0.030 |
Why?
|
| Anesthesia, Local | 1 | 2016 | 278 | 0.030 |
Why?
|
| Arginine | 1 | 2018 | 932 | 0.030 |
Why?
|
| Polysomnography | 1 | 2021 | 1871 | 0.030 |
Why?
|
| Hot Temperature | 1 | 2020 | 1441 | 0.030 |
Why?
|
| Cesarean Section | 1 | 2022 | 1425 | 0.030 |
Why?
|
| Patient Transfer | 1 | 2020 | 792 | 0.030 |
Why?
|
| Heart Septal Defects | 1 | 2014 | 191 | 0.030 |
Why?
|
| Wound Closure Techniques | 1 | 2014 | 88 | 0.030 |
Why?
|
| beta-Alanine | 1 | 2013 | 82 | 0.030 |
Why?
|
| Inflammation | 1 | 2012 | 10873 | 0.030 |
Why?
|
| Specialization | 1 | 2017 | 779 | 0.030 |
Why?
|
| Sample Size | 1 | 2015 | 846 | 0.030 |
Why?
|
| Reoperation | 1 | 2022 | 4329 | 0.020 |
Why?
|
| Infant, Premature | 1 | 2021 | 2124 | 0.020 |
Why?
|
| Chronic Disease | 2 | 2022 | 9384 | 0.020 |
Why?
|
| Respiratory Insufficiency | 1 | 2020 | 1240 | 0.020 |
Why?
|
| Emergencies | 1 | 2018 | 1221 | 0.020 |
Why?
|
| Demography | 1 | 2015 | 1641 | 0.020 |
Why?
|
| Creatinine | 1 | 2016 | 1918 | 0.020 |
Why?
|
| Morpholines | 1 | 2013 | 584 | 0.020 |
Why?
|
| Patient Admission | 1 | 2017 | 1365 | 0.020 |
Why?
|
| Thromboembolism | 1 | 2016 | 1004 | 0.020 |
Why?
|
| Schools | 1 | 2019 | 1498 | 0.020 |
Why?
|
| International Cooperation | 1 | 2015 | 1436 | 0.020 |
Why?
|
| Animals | 1 | 2021 | 169246 | 0.020 |
Why?
|
| Aged, 80 and over | 1 | 2014 | 59629 | 0.020 |
Why?
|
| Thiophenes | 1 | 2013 | 570 | 0.020 |
Why?
|
| Linear Models | 1 | 2019 | 5884 | 0.020 |
Why?
|
| Sulfonamides | 1 | 2018 | 1982 | 0.020 |
Why?
|
| Benzimidazoles | 1 | 2013 | 864 | 0.020 |
Why?
|
| Kaplan-Meier Estimate | 1 | 2018 | 6526 | 0.020 |
Why?
|
| Self Report | 1 | 2018 | 3773 | 0.020 |
Why?
|
| Communication | 1 | 2021 | 3905 | 0.020 |
Why?
|
| Health Personnel | 1 | 2020 | 3385 | 0.020 |
Why?
|
| Respiration, Artificial | 1 | 2018 | 2726 | 0.020 |
Why?
|
| Aspirin | 1 | 2018 | 3135 | 0.020 |
Why?
|
| Cardiovascular Diseases | 1 | 2012 | 15662 | 0.020 |
Why?
|
| Radiography, Thoracic | 1 | 2012 | 1321 | 0.020 |
Why?
|
| Anesthetics | 1 | 2009 | 525 | 0.010 |
Why?
|
| Renal Dialysis | 1 | 2013 | 1791 | 0.010 |
Why?
|
| Body Weight | 1 | 2014 | 4627 | 0.010 |
Why?
|
| Exercise | 1 | 2018 | 5955 | 0.010 |
Why?
|
| Drug Therapy, Combination | 1 | 2009 | 6316 | 0.010 |
Why?
|
| Cross-Sectional Studies | 1 | 2021 | 26379 | 0.010 |
Why?
|
| Clinical Trials as Topic | 1 | 2015 | 8054 | 0.010 |
Why?
|
| Physicians | 1 | 2015 | 4598 | 0.010 |
Why?
|